Why the study?
Does glycosylated hemoglobin (Hb A1) measurement help identify previously unrecognized diabetes in nondiabetic patients admitted with suspected myocardial infarction?
Does glycosylated hemoglobin (Hb A1) measurement help identify previously unrecognized diabetes in nondiabetic patients admitted with suspected myocardial infarction?
Answers are grounded in this paper and cite their sources.
Hb A1 measurement is a practical method to differentiate stress-induced hyperglycemia from previously unrecognized diabetes in patients admitted with suspected MI.
All nondiabetic patients admitted to a coronary care unit with suspected myocardial infarction (MI) had glycosylated hemoglobin (Hb A1) determinations to aid in the interpretation of hyperglycemia. Hyperglycemia was frequent among patients with a confirmed MI, whereas an elevated Hb A1 level was less common and affected patients with and without MI equally. With the use of a fasting plasma glucose level of 140 mg/dL and an Hb A1 level of more than 8.5% as combined diagnostic criteria, 9% of patients (8/93) with MI and 12% of patients (8/68) without MI had previously unrecognized diabetes. Follow-up studies three months after the acute episode supported these results. The Hb A1 measurements provide a practical method to separate hyperglycemia due to stress from that due to diabetes mellitus. Marked hyperglycemia with a normal Hb A1 level indicates a severe MI.
No takes yet. Share an insight, caveat, or question.
Norman G. Soler (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: